Nasopharyngeal radiotherapy causes substantial weight loss despite modern treatment

One-third of patients developed malnutrition during nasopharyngeal RT, while prophylactic enteral nutrition was associated with better post-treatment weight stabilization.

KEY POINTS

  • The French multicenter DRAKAR study retrospectively included 124 patients treated with curative-intent radiotherapy for primary nasopharyngeal cancer between 2015 and 2024. Undifferentiated carcinoma of nasopharyngeal type accounted for 59.7%, squamous cell carcinoma for 40.3%, and 87.9% received chemoradiotherapy.
  • Nutritional deterioration was substantial. Mean weight change was −3.79% after one month of RT, −6.45% at treatment completion, and −7.79% three months later.
  • Moderate or severe malnutrition was present in approximately 8% before treatment but increased to 35.5% after one month of RT, including 30.7% with moderate and 4.8% with severe malnutrition.
  • Enteral nutrition was required in 55.6% of patients; only 16.1% received it prophylactically before RT. Patients selected for prophylactic support actually entered treatment with greater prior weight loss, but their weight subsequently stabilized after treatment while patients without prophylactic support continued to lose weight.
  • Younger age was the clearest independent risk factor. Patients younger than 55 had 2.62-fold higher odds of moderate or severe malnutrition at one month (95% CI 1.21–5.88; p=0.016).
  • Severe acute toxicity was frequent: grade ≥3 mucositis occurred in 31.5% and grade ≥3 radiation-induced nausea/vomiting in 14.5%. Female sex was associated with severe nausea/vomiting, while larger intermediate-risk CTV volume was associated with severe mucositis.
  • IMPT substantially reduced dorsal vagal complex exposure in the dosimetric subset: mean dose was 17.7 Gy with IMPT versus 29.4 Gy with IMRT (p<0.01). However, this dosimetric advantage did not translate into a demonstrated reduction in severe nausea/vomiting, and prophylactic enteral nutrition did not reduce hospitalization or improve overall survival.

CLINICAL TAKEAWAY

Nutritional toxicity during nasopharyngeal chemoradiotherapy remains substantial even with modern RT, and deterioration begins early enough that waiting for major weight loss may be too late for some patients. Prophylactic enteral nutrition showed a signal for improved post-treatment weight stabilization, but selection bias prevents causal conclusions and prospective risk-adapted studies are needed.

SOURCE

Clinical and Translational Radiation Oncology

Browse more research Suggest a correction